Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne Galy

Showing results (81-90 of 108) with videos related to

Pageof 11
Sort By:
Molecular Therapy. Methods & Clinical Development|March 6, 2023
Intravitreal air tamponade after AAV2 subretinal injection modifies retinal EGFP distributionJean-Baptiste Ducloyer, Virginie Pichard, Mathieu Mevel, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 4, 2024
An empowered, clinically viable hematopoietic stem cell gene therapy for the treatment of multisystemic mucopolysaccharidosis type IISabyasachi Das, Fatlum Rruga, Annita Montepeloso, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 31, 2016
Treatment of Uveitis by In Situ Administration of Ex Vivo-Activated Polyclonal Regulatory T CellsSylvie Grégoire, Céline Terrada, Gaelle H Martin, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 5, 2009
Evidence for long-term efficacy and safety of gene therapy for Wiskott-Aldrich syndrome in preclinical modelsFrancesco Marangoni, Marita Bosticardo, Sabine Charrier, et al.
Nature Immunology|February 25, 2003
An essential role for tripeptidyl peptidase in the generation of an MHC class I epitopeUlrike Seifert, Concepción Marañón, Ayelet Shmueli, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 9, 2017
Corrigendum to "Evidence for Long-term Efficacy and Safety of Gene Therapy for Wiskott-Aldrich Syndrome in Preclinical Models"Francesco Marangoni, Marita Bosticardo, Sabine Charrier, et al.
Blood|August 13, 2017
Engraftment and in vivo proliferation advantage of gene-corrected mobilized CD34<sup>+</sup> cells from Fanconi anemia patientsPaula Río, Susana Navarro, Guillermo Guenechea, et al.
Plos One|September 26, 2013
Heterozygous and homozygous JAK2(V617F) states modeled by induced pluripotent stem cells from myeloproliferative neoplasm patientsJoseph Saliba, Sofiane Hamidi, Gaëlle Lenglet, et al.
Plos Genetics|November 9, 2013
Human intellectual disability genes form conserved functional modules in DrosophilaMerel A W Oortveld, Shivakumar Keerthikumar, Martin Oti, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 19, 2008
Stable and functional lymphoid reconstitution in artemis-deficient mice following lentiviral artemis gene transfer into hematopoietic stem cellsFatine Benjelloun, Alexandrine Garrigue, Corinne Demerens-de Chappedelaine, et al.
Pageof 11

Showing results (81-90 of 108) with videos related to

Sort By:
Pageof 11
Molecular Therapy. Methods & Clinical Development|March 6, 2023
Intravitreal air tamponade after AAV2 subretinal injection modifies retinal EGFP distributionJean-Baptiste Ducloyer, Virginie Pichard, Mathieu Mevel, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 4, 2024
An empowered, clinically viable hematopoietic stem cell gene therapy for the treatment of multisystemic mucopolysaccharidosis type IISabyasachi Das, Fatlum Rruga, Annita Montepeloso, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 31, 2016
Treatment of Uveitis by In Situ Administration of Ex Vivo-Activated Polyclonal Regulatory T CellsSylvie Grégoire, Céline Terrada, Gaelle H Martin, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 5, 2009
Evidence for long-term efficacy and safety of gene therapy for Wiskott-Aldrich syndrome in preclinical modelsFrancesco Marangoni, Marita Bosticardo, Sabine Charrier, et al.
Nature Immunology|February 25, 2003
An essential role for tripeptidyl peptidase in the generation of an MHC class I epitopeUlrike Seifert, Concepción Marañón, Ayelet Shmueli, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 9, 2017
Corrigendum to "Evidence for Long-term Efficacy and Safety of Gene Therapy for Wiskott-Aldrich Syndrome in Preclinical Models"Francesco Marangoni, Marita Bosticardo, Sabine Charrier, et al.
Blood|August 13, 2017
Engraftment and in vivo proliferation advantage of gene-corrected mobilized CD34<sup>+</sup> cells from Fanconi anemia patientsPaula Río, Susana Navarro, Guillermo Guenechea, et al.
Plos One|September 26, 2013
Heterozygous and homozygous JAK2(V617F) states modeled by induced pluripotent stem cells from myeloproliferative neoplasm patientsJoseph Saliba, Sofiane Hamidi, Gaëlle Lenglet, et al.
Plos Genetics|November 9, 2013
Human intellectual disability genes form conserved functional modules in DrosophilaMerel A W Oortveld, Shivakumar Keerthikumar, Martin Oti, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 19, 2008
Stable and functional lymphoid reconstitution in artemis-deficient mice following lentiviral artemis gene transfer into hematopoietic stem cellsFatine Benjelloun, Alexandrine Garrigue, Corinne Demerens-de Chappedelaine, et al.
Pageof 11